https://orcid.org/0000-0002-7701-8597
Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vivek Chavda, Rajashri Bezbaruah, Tutumoni Kalita, Anupam Sarma, Juti Rani Devi, Ratnali Bania & Vasso Apostolopoulos. (2022) Variant influenza: connecting the missing dots. Expert Review of Anti-infective Therapy 20:12, pages 1567-1585.
Read now
Read now
Vivek P. Chavda, Yangmin Chen, Jayant Dave, Zhe-Sheng Chen, Subhash C. Chauhan, Murali M. Yallapu, Vladimir N. Uversky, Rajashri Bezbaruah, Sandip Patel & Vasso Apostolopoulos. (2022) COVID-19 and vaccination: myths vs science. Expert Review of Vaccines 21:11, pages 1603-1620.
Read now
Read now
Vivek P. Chavda, Melina Haritopoulou-Sinanidou, Rajashri Bezbaruah & Vasso Apostolopoulos. (2022) Vaccination efforts for Buruli ulcer. Expert Review of Vaccines 21:10, pages 1419-1428.
Read now
Read now
Vivek P. Chavda, Aayushi B. Patel, Lalitkumar K. Vora, Vasso Apostolopoulos & Bruce D. Uhal. (2022) Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management. Expert Review of Vaccines 21:10, pages 1395-1403.
Read now
Read now
Vivek P Chavda, Riddhi Prajapati, Disha Lathigara, Bhumi Nagar, Jay Kukadiya, Elrashdy M Redwan, Vladimir N Uversky, Mukesh N Kher & Rajvi Patel. (2022) Therapeutic monoclonal antibodies for COVID-19 management: an update. Expert Opinion on Biological Therapy 22:6, pages 763-780.
Read now
Read now
Articles from other publishers (40)
Lyubov A. Kisakova, Evgeny K. Apartsin, Lily F. Nizolenko & Larisa I. Karpenko. (2023) Dendrimer-Mediated Delivery of DNA and RNA Vaccines. Pharmaceutics 15:4, pages 1106.
Crossref
Crossref
Raman Singh, Vidushi Gupta, Antresh Kumar & Kuldeep Singh. (2023) 2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities. Advances in Pharmacological and Pharmaceutical Sciences 2023, pages 1-15.
Crossref
Crossref
Qunjie Bi, Xu Song, Yangyang Zhao, Xueyi Hu, Huan Yang, Rongrong Jin & Yu Nie. (2023) Mucus-penetrating nonviral gene vaccine processed in the epithelium for inducing advanced vaginal mucosal immune responses. Acta Pharmaceutica Sinica B 13:3, pages 1287-1302.
Crossref
Crossref
Shalin Parikh, Ravi Patel, Dignesh Khunt, Vivek P. Chavda & Lalitkumar Vora. 2023. Bioinformatics Tools for Pharmaceutical Drug Product Development. Bioinformatics Tools for Pharmaceutical Drug Product Development
55
76
.
Prashant Pokhriyal, Vivek P. Chavda & Mili Pathak. 2023. Bioinformatics Tools for Pharmaceutical Drug Product Development. Bioinformatics Tools for Pharmaceutical Drug Product Development
401
416
.
Rajashri Bezbaruah, Mainak Ghosh, Shuby Kumari, Lawandashisha Nongrang, Sheikh Rezzak Ali, Monali Lahiri, Hasmi Waris & Bibhuti Bhushan Kakoti. 2023. Bioinformatics Tools for Pharmaceutical Drug Product Development. Bioinformatics Tools for Pharmaceutical Drug Product Development
345
369
.
Abdul Aziz Al-Fattah Yahaya, Kanwal Khalid, Hui Xuan Lim & Chit Laa Poh. (2023) Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern. Viruses 15:3, pages 624.
Crossref
Crossref
Vivek P. Chavda, Gargi Jogi, Srusti Dave, Bhoomika M. Patel, Lakshmi Vineela Nalla & Krishna Koradia. (2023) mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!. Vaccines 11:3, pages 507.
Crossref
Crossref
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, Bindra Patel, Anup Kumar, Sanjay Prasad, Bibhuti Bhusan Kakoti, Ajeet Kaushik & Mariya Jesawadawala. (2023) Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status. Vaccines 11:2, pages 432.
Crossref
Crossref
Patrick O. Azevedo, Natália S. Hojo-Souza, Lídia P. Faustino, Marcílio J. Fumagalli, Isabella C. Hirako, Emiliano R. Oliveira, Maria M. Figueiredo, Alex F. Carvalho, Daniel Doro, Luciana Benevides, Edison Durigon, Flávio Fonseca, Alexandre M. Machado, Ana P. Fernandes, Santuza R. Teixeira, João S. Silva & Ricardo T. Gazzinelli. (2023) Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern. npj Vaccines 8:1.
Crossref
Crossref
Vivek Chavda, Disha Valu, Palak Parikh, Nikita Tiwari, Abu Chhipa, Somanshi Shukla, Snehal Patel, Pankti Balar, Ana Paiva-Santos & Vandana Patravale. (2023) Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants. Vaccines 11:2, pages 374.
Crossref
Crossref
Ahmed I. Abulsoud, Hussein M. El-Husseiny, Ahmed A. El-Husseiny, Hesham A. El-Mahdy, Ahmed Ismail, Samy Y. Elkhawaga, Emad Gamil Khidr, Doaa Fathi, Eman A. Mady, Agnieszka Najda, Mohammad Algahtani, Abdulrahman Theyab, Khalaf F. Alsharif, Ashraf Albrakati, Roula Bayram, Mohamed M. Abdel-Daim & Ahmed S. Doghish. (2023) Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions. Biomedicine & Pharmacotherapy 157, pages 113977.
Crossref
Crossref
Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, Shruti Soni, Avinash Khadela & Jinal Ajabiya. (2022) mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10:12, pages 2150.
Crossref
Crossref
Vivek P. Chavda, Aayushi B. Patel, Lalitkumar K. Vora, Rajeev K. Singla, Priyal Shah, Vladimir N. Uversky & Vasso Apostolopoulos. (2022) Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for
the Treatment of COVID-19. Current Pharmaceutical Design 28:46, pages 3658-3670.
Crossref
Crossref
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Aayushi B. Patel, Nikita Sharma & Zhe-Sheng Chen. (2022) Recent review of COVID-19 management: diagnosis, treatment and vaccination. Pharmacological Reports 74:6, pages 1120-1148.
Crossref
Crossref
M. B. Borgoyakova, L. I. Karpenko, I. A. Merkulyeva, D. N. Shcherbakov, A. P. Rudometov, E. V. Starostina, D. V. Shanshin, A. A. Isaeva, V. S. Nesmeyanova, N. V. Volkova, S. V. Belenkaya, E. A. Volosnikova, A. M. Zadorozhny, L. A. Orlova, A. V. Zaykovskaya, O. V. Pyankov, S. I. Bazhan & A. A. Ilyichev. (2023) Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19. Bulletin of Experimental Biology and Medicine 174:2, pages 246-249.
Crossref
Crossref
Vivek P. Chavda & Elrashdy M. Redwan. (2022) SARS-CoV-2: Immunopeptidomics and Other Immunological Studies. Vaccines 10:11, pages 1975.
Crossref
Crossref
Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki & Vasso Apostolopoulos. (2022) The Vaccine World of COVID-19: India’s Contribution. Vaccines 10:11, pages 1943.
Crossref
Crossref
Vivek Chavda, Rajashri Bezbaruah, Kangkan Deka, Lawandashisha Nongrang & Tutumoni Kalita. (2022) The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far. Vaccines 10:11, pages 1926.
Crossref
Crossref
Denis N. Kisakov, Lyubov A. Orlova, Сергей V. Sharabrin, Andrey P. Rudometov, Maria B. Borgoyakova, Ekaterina V. Starostina, Larisa I. Karpenko & Alexander A. Ilyichev. (2022) Delivery of a DNA vaccine encoding SARS-CoV-2 receptor-binding domain (RBD) by electroporation. Medical academic journal 2:2, pages 191-196.
Crossref
Crossref
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, Xingyun Wang, Yunjiao He & Peng George Wang. (2022) Strategy of developing nucleic acid-based universal monkeypox vaccine candidates. Frontiers in Immunology 13.
Crossref
Crossref
Chen Zhang, Peng-Qi Zhang, Sheng Guo, Zhao Zhao, Gao-Xue Wang & Bin Zhu. (2022) Dual-Targeting Polymer Nanoparticles Efficiently Deliver DNA Vaccine and Induce Robust Prophylactic Immunity against Spring Viremia of Carp Virus Infection. Microbiology Spectrum 10:5.
Crossref
Crossref
Denis Nikolaevich Kisakov, Lyubov Alexandrovna Kisakova, Maria Borisovna Borgoyakova, Ekaterina Vladimirovna Starostina, Oleg Svyatoslavovich Taranov, Elena Konstantinovna Ivleva, Oleg Viktorovich Pyankov, Anna Vladimirovna Zaykovskaya, Dmitry Nikolaevich Shcherbakov, Andrey Pavlovich Rudometov, Nadezda Borisovna Rudometova, Natalia Vyacheslavovna Volkova, Vadim Nikolaevich Gureev, Alexander Alexeyevich Ilyichev & Larisa Ivanovna Karpenko. (2022) Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol. Pharmaceutics 14:11, pages 2259.
Crossref
Crossref
Vivek P Chavda, Aayushi B Patel, Anjali Pandya, Lalitkumar K Vora, Vandana Patravale, Zara M Tambuwala, Alaa AA Aljabali, Ángel Serrano-Aroca, Vijay Mishra & Murtaza M Tambuwala. (2022) Co-infection associated with SARS-CoV-2 and their management. Future Science OA 8:9.
Crossref
Crossref
Vijay Rani Rajpal, Shashi Sharma, Deepmala Sehgal, Apekshita Singh, Avinash Kumar, Samantha Vaishnavi, Mugdha Tiwari, Hemal Bhalla, Shailendra Goel & Soom Nath Raina. (2022) A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program. Future Virology 17:9, pages 687-706.
Crossref
Crossref
Yuan Liu & Bin Wu. (2022) Coevolution of vaccination behavior and perceived vaccination risk can lead to a stag-hunt-like game. Physical Review E 106:3.
Crossref
Crossref
Vivek P. Chavda, Anup Kumar, Rittwika Banerjee & Nayan Das. (2022) Ayurvedic and Other Herbal Remedies for Dengue: An Update. Clinical Complementary Medicine and Pharmacology 2:3, pages 100024.
Crossref
Crossref
Vivek P. Chavda, Shreya S. Sonak, Nafesa K. Munshi & Pooja N. Dhamade. (2022) Pseudoscience and fraudulent products for COVID-19 management. Environmental Science and Pollution Research 29:42, pages 62887-62912.
Crossref
Crossref
Saeed Khoshnood, Roya Ghanavati, Maryam Shirani, Hossein Ghahramanpour, Mohammad Sholeh, Aref Shariati, Nourkhoda Sadeghifard & Mohsen Heidary. (2022) Viral vector and nucleic acid vaccines against COVID-19: A narrative review. Frontiers in Microbiology 13.
Crossref
Crossref
Vivek P. Chavda, Lalitkumar K. Vora & Vasso Apostolopoulos. (2022) Inhalable Vaccines: Can They Help Control Pandemics?. Vaccines 10:8, pages 1309.
Crossref
Crossref
Vivek P. Chavda, Aayushi B. Patel & Darsh D. Vaghasiya. (2022) SARS‐CoV‐2 variants and vulnerability at the global level. Journal of Medical Virology 94:7, pages 2986-3005.
Crossref
Crossref
Xingyun Wang, Nino Rcheulishvili, Jie Cai, Cong Liu, Fengfei Xie, Xing Hu, Nuo Yang, Mengqi Hou, Dimitri Papukashvili, Yunjiao He & Peng George Wang. (2022) Development of DNA Vaccine Candidate against SARS-CoV-2. Viruses 14:5, pages 1049.
Crossref
Crossref
Zoufang Huang, Vivek P. Chavda, Lalitkumar K. Vora, Normi Gajjar, Vasso Apostolopoulos, Nirav Shah & Zhe-Sheng Chen. (2022) 2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update. Frontiers in Pharmacology 13.
Crossref
Crossref
Vivek P. Chavda, Rajashri Bezbaruah, Mansi Athalye, Palak K. Parikh, Abu Sufiyan Chhipa, Snehal Patel & Vasso Apostolopoulos. (2022) Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena. Viruses 14:4, pages 759.
Crossref
Crossref
Vivek P Chavda, Carron Kapadia, Shailvi Soni, Riddhi Prajapati, Subhash C Chauhan, Murali M Yallapu & Vasso Apostolopoulos. (2022) A global picture: therapeutic perspectives for COVID-19. Immunotherapy 14:5, pages 351-371.
Crossref
Crossref
Vivek P Chavda, Aayushi B. Patel, Disha Vihol, Darsh D. Vaghasiya, Khandu Muhammed Saad Bashir Ahmed, Kushal U. Trivedi & Divyang J Dave. (2022) Herbal Remedies, Nutraceuticals, and Dietary Supplements for COVID-19 Management: An Update. Clinical Complementary Medicine and Pharmacology 2:1, pages 100021.
Crossref
Crossref
Vivek P. Chavda & Vasso Apostolopoulos. (2022) Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?. Vaccines 10:3, pages 367.
Crossref
Crossref
Mariya B. Borgoyakova, Larisa I. Karpenko, Andrey P. Rudometov, Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Ekaterina V. Starostina, Alexey M. Zadorozhny, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Daniil V. Shanshin, Konstantin O. Baranov, Natalya V. Volkova, Boris N. Zaitsev, Lyubov A. Orlova, Anna V. Zaykovskaya, Oleg V. Pyankov, Elena D. Danilenko, Sergei I. Bazhan, Dmitry N. Shcherbakov, Alexander V. Taranin & Alexander A. Ilyichev. (2022) Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice. International Journal of Molecular Sciences 23:4, pages 2188.
Crossref
Crossref
Debdoot Basu, Vivek P. Chavda & Anita A. Mehta. (2022) Therapeutics for COVID-19 and post COVID-19 complications: An update. Current Research in Pharmacology and Drug Discovery 3, pages 100086.
Crossref
Crossref
Vivek P. Chavda, Md Kamal Hossain, Jayesh Beladiya & Vasso Apostolopoulos. (2021) Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena. Biologics 1:3, pages 337-356.
Crossref
Crossref